Paper presentation on Uterine Fibroids Impact only on Women’s Health and Quality of Life for gynec resident
Asking for Preferences
Reading File
Finding Sources
Searching PubMed
"uterine fibroids" AND "quality of life"
Searching the Web
uterine fibroids impact women health quality of life 2024 epidemiology burden
Finding Sources
Reading Article
Reading Web Page
uterine fibroids global burden epidemiology prevalence quality of life
Finding Sources
Searching PubMed
"uterine fibroids" AND "fertility" AND "pregnancy outcomes"
Reading File
Reading File
Finding Sources
Reading File
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Running Command
Writing File
Running Command
Editing File
Running Command
Running Command
Your PDF presentation is ready!
Uterine Fibroids Impact QoL Gynec Residents
PDF Document · PDF
What's Inside (14 slides)
| # | Slide Title |
|---|---|
| 1 | Cover - with 4 headline statistics |
| 2 | Presentation Overview - table of contents |
| 3 | Definition, Classification & Epidemiology - FIGO 0-8 subtype table, GBD 2025 burden data |
| 4 | Pathogenesis & Risk Factors - MED12, HMGA2, hormonal drivers; modifiable vs non-modifiable table |
| 5 | Clinical Manifestations - 7-domain symptom table (HMB, pain, bulk, anemia, reproductive, sexual, urological) |
| 6 | Reproductive Health & Fertility - infertility mechanisms, obstetric complications (Creasy & Resnik MFM) |
| 7 | Quality of Life Domains - UFS-QoL instrument; subscale scores from published studies |
| 8 | Psychological, Social & Sexual Impact - fear data (Mayo Clinic 1000-women survey), treatment delay |
| 9 | Economic Burden & Workplace Impact - $34.4B annual US burden, 66% worried about missed work |
| 10 | Investigation & Diagnosis - TVUS/MRI/SIS roles, red flags for leiomyosarcoma |
| 11 | Management Overview - expectant, medical, minimally invasive, UAE, myomectomy, hysterectomy |
| 12 | QoL Outcomes Post-Treatment - Neumann et al. 2024 (Fertil Steril, 67 studies) - all modalities compared |
| 13 | Key Messages & Conclusions - 7 take-home points |
| 14 | References - 15 sources (textbooks + recent systematic reviews 2022-2025) |
Key sources used: Berek & Novak's Gynecology, Robbins Pathology (10th ed.), Creasy & Resnik MFM, plus 10 recent PubMed systematic reviews and meta-analyses (2022-2025) including the GBD 2025 global burden analysis.
This is a shared conversation. Sign in to Orris to start your own chat.